UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity

BMC medical education, 2023, Vol.23 (1), p.1-635, Article 635

2023

Volltextzugriff (PDF)

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (4), p.379

2017

Volltextzugriff (PDF)

Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

Diabetes technology & therapeutics, 2020-10, Vol.22 (10), p.709-718

2020

Volltextzugriff (PDF)

The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Diabetes care, 2020-09, Vol.43 (9), p.2017-2024

2020

Volltextzugriff (PDF)

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Diabetes care, 2021-01, Vol.44 (1), p.141-149

2021

Volltextzugriff (PDF)

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Diabetes technology & therapeutics, 2018-04, Vol.20 (4), p.274-284

2018

Volltextzugriff (PDF)

Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Diabetes, obesity & metabolism, 2024-01, Vol.26 (1), p.301-310

2024

Volltextzugriff (PDF)

Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Diabetologia, 2024, Vol.67 (8), p.1517

2024

Volltextzugriff (PDF)

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Diabetologia, 2024, Vol.67 (8), p.1517-1526

2024

Volltextzugriff (PDF)

Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Diabetes care, 2021, Vol.44 (1), p.141

2021

Volltextzugriff (PDF)

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Journal of diabetes science and technology, 2024-01, Vol.18 (1), p.89-98

2024

Volltextzugriff (PDF)

1076-P: Increased Time-in-Range (TIR) Observed after Introduction of a Connected Insulin Pen

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

126-LB: Improved Insulin Adherence after Introduction of a Smart Connected Insulin Pen

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

The Association Between HbA 1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Diabetes care, 2020-09, Vol.43 (9), p.2017

2020

Volltextzugriff (PDF)

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Journal of diabetes science and technology, 2024, Vol.18 (1), p.89

2024

Volltextzugriff (PDF)

Sustained Intensive Treatment and Long-term Effects on HbA 1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Diabetes care, 2021-01, Vol.44 (1), p.141

2021

Volltextzugriff (PDF)

Cost savings associated with CSII therapy compared to MDI in a Swedish setting

Diabetologia, 2015, Vol.58 (Suppl. 1), p.S477

2015

Volltextzugriff (PDF)

64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.619-630

2021

Volltextzugriff (PDF)

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Journal of diabetes science and technology, 2023, Vol.In Press, p.19322968231183974-19322968231183974

2023

Volltextzugriff (PDF)

The Association Between HbA(1c)and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Diabetes care, 2020, Vol.43 (9), p.2017

2020

Volltextzugriff (PDF)

Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Diabetes therapy, 2023-06, Vol.14 (6), p.953-965

2023

Volltextzugriff (PDF)

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Diabetes therapy, 2023-09, Vol.14 (9), p.1563-1575

2023

Volltextzugriff (PDF)

Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

Journal of cystic fibrosis, 2014, Vol.13 (2), p.S126

2014

Volltextzugriff (PDF)

EPA – en modell för att träna och bedöma dagligt läkarjobb [EPA (Entrustable professional activities) - an international approach to define key tasks that a doctor should be able to perform]

Läkartidningen, 2019, Vol.116

2019

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(26)
Schwedisch
(6)

Erscheinungsjahr

n.n

Thema

Diabetes
(14)
Medicin Och Hälsovetenskap
(13)
Insulin
(12)
Endocrinology & Metabolism
(11)
Hypoglycemia
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Endocrinology And Diabetes
(10)
Endokrinologi Och Diabetes
(10)
Diabetes Mellitus
(9)
Glucose
(8)
Glucose Monitoring
(8)
Humans
(8)
Diabetes Mellitus, Type 1 - Drug Therapy
(7)
Type 1 Diabetes
(7)
Blood Glucose Self-Monitoring
(6)
Continuous Glucose Monitoring
(6)
Blood Glucose
(5)
Clinical Medicine
(5)
Endocrinology And Diabetology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

1076-P: Increased Time-in-Range (TIR) Observed after Introduction of a Connected Insulin Pen

126-LB: Improved Insulin Adherence after Introduction of a Smart Connected Insulin Pen

The Association Between HbA 1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Sustained Intensive Treatment and Long-term Effects on HbA 1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Cost savings associated with CSII therapy compared to MDI in a Swedish setting

64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

The Association Between HbA(1c)and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

EPA – en modell för att träna och bedöma dagligt läkarjobb [EPA (Entrustable professional activities) - an international approach to define key tasks that a doctor should be able to perform]

Suchergebnisse filtern